| Scholar Rock Holding | Phase 3 | $5.7B | Neuromuscular, Cardiometabolic Disorders |
| Scholar Rock | Phase 3 | $5.6B | Neuromuscular, Cardiometabolic |
| Erasca | Phase 1b/2 | $3.3B | Oncology, Precision Oncology |
| Prime Medicine | Phase 1/2 | $578.0M | Rare Genetic Diseases, Genetic Medicine |
| Neumora Therapeutics | Phase 3 | $340.7M | Neuropsychiatry, Neurodegeneration |
| Blank Bio | platform | — | Genetic Diseases, Oncology |
| CellThera AI | platform | — | Oncology, Autoimmune Diseases |
| Hua Medicine | commercial | — | Metabolic |
| Rome Therapeutics | preclinical | — | Oncology, Immunology |
| Rezo Therapeutics | preclinical | — | Oncology |
| Altos Labs | Pre-clinical | — | Age-related Diseases, Neurodegenerative Disorders |
| InduPro | platform | — | Oncology, Immunology |
| Perimeter Systems, Inc. | preclinical | — | Oncology |
| Human Immunology Biosciences (HI-Bio) | phase-2 | — | Immunology, Rare Disease |
| Seaport Therapeutics | phase-2 | — | Neuroscience, Psychiatry |
| Kardigan | Phase 2 | — | Cardiovascular |
| Bitterroot Bio | Pre-clinical | — | Cardiovascular Disease, Atherosclerosis |
| Lifordi Immunotherapeutics | Phase 1 | — | Autoimmune Disorders, Inflammatory Disorders |
| Synchron | Phase 1 | — | Neurology, Severe Paralysis |
| Magnet Biomedicine | Pre-clinical | — | Oncology, Immune Disorders |
| Dispatch Bio | Pre-clinical | — | Oncology, Solid Tumors |
| Be Biopharma | Phase 1 | — | Rare Diseases, Hematology |
| Protillion Biosciences | Pre-clinical | — | — |
| RhyGaze | Pre-clinical | — | Ophthalmology, Retinal Diseases |
| Moleculent | — | — | Oncology, Immunology |
| Pelage Pharmaceuticals | Phase 2 | — | Dermatology, Hair Loss (Alopecia) |
| Sonoma Biotherapeutics | Phase 1 | — | Autoimmune Diseases, Inflammatory Diseases |
| AIRNA | Pre-clinical | — | Oncology, Rare Diseases |
| Maven Bio | preclinical | — | Oncology, Immunology |
| Ligo Biosciences | platform | — | Oncology, Immunology |
| Kopra Bio | preclinical | — | Oncology, Immunology |
| Viome | commercial | — | Microbiome, Digestive Health |
| Bolt Threads | commercial | — | — |
| Superluminal Medicines | preclinical | — | Neuroscience, Psychiatry |
| Manakin Bio | preclinical | — | Infectious Diseases |
| NeuroDx | commercial | — | Neuroscience, Diagnostics |
| Timberlyne Therapeutics | preclinical | — | Neuroscience, Psychiatry |
| Aera Therapeutics | preclinical | — | Gene Therapy, Rare Diseases |
| Converge Bio | platform | — | Oncology, Immunology |
| Sironax | phase-1 | — | Ophthalmology, Neuroscience |
| Tome Biosciences | preclinical | — | Genetic Diseases, Oncology |
| CellForge | phase-2 | — | Oncology, Immunology |
| Corxel Pharmaceuticals | preclinical | — | Oncology, Immunology |
| Immunai | platform | — | Oncology, Immunology |
| ImmunoLogic | phase-2 | — | Infectious Disease, Immunology |
| Odyssey Therapeutics | phase-1 | — | Oncology, Immunology |
| KAHR Medical | preclinical | — | Genetic Disorders, Oncology |
| ReNAgade Therapeutics | preclinical | — | Genetic Diseases, Neurology |
| Mirador Therapeutics | preclinical | — | Immunology, Respiratory |
| LifeMine Therapeutics | preclinical | — | Oncology, Immunology |